The Business of Digital Therapeutics

27th October @ 3.00pm GMT+1/ 11am EDT
Digital Health Lunch

The Business of Digital Therapeutics

27th October @ 3.00pm GMT+1/ 11am EDT
Digital Health Lunch

HealthXL virtual lunches convene small groups of thought leads and clients to share insights on key digital health issues. We welcome new experts and clients to join or host their own meetings. If you are interested in this topic, we would love to hear from you.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.

Keith O'Neill
Director, Innovation Alliances at Abbott Medicines
LinkedIn Profile
Gangadhar Garipelli
Director of Clinical Development, Digital Therapeutics, MindMaze
LinkedIn Profile
Lisa Suennen
Managing Partner, Venture Valkyrie and Group Leader, Manatt Ventures
LinkedIn Profile
Stephen Dunne
Chief Digital Therapeutics Officer (CDTxO) at Alpha
LinkedIn Profile
Karl Hess
Managing Director, OnDigitalHealth Couslting, LLC
LinkedIn Profile
Rick Bartels
Managing Partner , DTxCC
LinkedIn Profile
Stephen Egan
Director, Redicare
LinkedIn Profile
Victor Chan
Digital Health Platform Strategy Lead at Genentech
LinkedIn Profile
Lorenna Feliz Santos
CEO & Founder, DiaM Life
LinkedIn Profile
Kati (Saari) Kaijasilta
Business Development Director, Orion Corporation
LinkedIn Profile

In small, private groups of up to 10 people, you can discuss challenges and questions that you have. Apply for one of our digital health meetings and we will match you with peers that allow you to review failures, successes and developments.

Digital Health Lunch
When:
27th October @ 3.00pm GMT+1/ 11am EDT
Register your interest
Registration Closed

What business models have worked for DTx companies? D2C or partnership with a pharma company or something else? Have we cracked the different routes to market to build sustainable and scalable businesses out of DTx? Who is doing it well and why? 


Keith O'Neill
Director, Innovation Alliances at Abbott Medicines
LinkedIn Profile
Digital Health Lunch
When:
27th October @ 3.00pm GMT+1/ 11am EDT
Apply to Attend
Registration Closed

Attendees